GlassScriptPhysician profile
Bethany Dempsey
NPI 1497370381
$1,476.17
in general payments reported to CMS, 2019-2025
25 companies · $55.73 in 2025
The $55.73 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,385 · 2022: $35.20 · 2025: $55.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.67 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $186.13 | 2021-2025 | Fasenra |
| Dexcom, INC. | $122.34 | 2021 | |
| Amarin Pharma, INC. | $96.92 | 2021 | |
| Lilly USA, LLC | $91.76 | 2021 | |
| Amgen INC. | $75.11 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.16 | 2021 | |
| Merck Sharp & Dohme LLC | $67.08 | 2021 | |
| Astellas Pharma US INC | $65.47 | 2021 | |
| Novo Nordisk INC | $53.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $51.52 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $46.40 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.46 | 2021 | |
| Currax Pharmaceuticals LLC | $41.51 | 2021 | |
| Organon LLC | $35.20 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.32 | 2025 | Trelegy Ellipta |
| Ironshore Pharmaceuticals INC. | $20.35 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.60 | 2021 | |
| Antares Pharma, INC. | $19.05 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.99 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.67 | 2021 | |
| Vivus LLC | $13.99 | 2021 | |
| Alfasigma USA, INC. | $13.40 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.92 | 2021 | |
| Genentech USA, INC. | $4.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Dempsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.